Skip to content
Disclosery

MARSHALL WACE, LLP: CBIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on CBIO, newest first. How the timeline and the estimate are built.

MARSHALL WACE, LLP held 214,300 CBIO shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 214,300 shares
    Change vs previous 13F +13,520 shares

    <0.01% of the 13F portfolio, value $3,857,400.

    13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 200,780 shares
    Change vs previous 13F +178,954 shares

    <0.01% of the 13F portfolio, value $3,688,328.

    13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 21,826 shares
    Change vs previous 13F -21,868 shares

    <0.01% of the 13F portfolio, value $258,856.

    13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 43,694 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $519,522.

    13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).